ovalbumin and Disease-Resistance

ovalbumin has been researched along with Disease-Resistance* in 4 studies

Other Studies

4 other study(ies) available for ovalbumin and Disease-Resistance

ArticleYear
Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice.
    Cellular & molecular immunology, 2020, Volume: 17, Issue:10

    Progranulin is a secreted neurotrophin that assists in the autophagolysosomal pathways that contribute to MHC-mediated antigen processing, pathogen removal, and autoimmunity. We showed that patients with multiple sclerosis (MS) have high levels of circulating progranulin and that its depletion in a mouse model by a monoclonal antibody aggravates MS-like experimental autoimmune encephalomyelitis (EAE). However, unexpectedly, progranulin-deficient mice (Grn

    Topics: Adolescent; Adult; Animals; Antigen-Presenting Cells; Antigens; Bone Marrow; Bone Marrow Transplantation; Dendritic Cells; Disease Resistance; Encephalomyelitis, Autoimmune, Experimental; Female; Histocompatibility Antigens Class II; Humans; Lymphocyte Count; Macrophages; Male; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Myeloid Cells; Ovalbumin; Phagocytes; Phagocytosis; Progranulins; Scavenger Receptors, Class B; T-Lymphocytes; Young Adult

2020
Assessment of recent developmental immunotoxicity studies with bisphenol A in the context of the 2015 EFSA t-TDI.
    Reproductive toxicology (Elmsford, N.Y.), 2016, Volume: 65

    Humans are exposed to bisphenol A (BPA) mainly through the diet, air, dust, skin contact and water. There are concerns about adverse health effects in humans due to exposure to bisphenol A (BPA). The European Food Safety Authority (EFSA) has extensively reviewed the available literature to establish a temporary Tolerable Daily Intake (t-TDI). This exposure level was based on all available literature published before the end of 2012. Since then, new experimental animal studies have emerged, including those that identified effects of BPA on the immune system after developmental exposure. These studies indicate that developmental immunotoxicity might occur at lower dose levels than previously observed and on which the current EFSA t-TDI is based. The Dutch National Institute for Public Health and the Environment (RIVM) organized an expert workshop in September 2015 to consider recently published studies on the developmental immunotoxicity of bisphenol A (BPA). Key studies were discussed in the context of other experimental studies. The workshop concluded that these new experimental studies provide credible evidence for adverse immune effects after developmental exposure to BPA at 5μg/kg BW/day from gestation day 15 to postnatal day 21. Supportive evidence for adverse immune effects in similar dose ranges was obtained from other publications that were discussed during the workshop. The dose level associated with adverse immune effects is considerably lower than the dose used by EFSA for deriving the t-TDI. The workshop unanimously concluded that the current EFSA t-TDI warrants reconsideration in the context of all currently available data.

    Topics: Animals; Benzhydryl Compounds; Disease Resistance; Female; Food Safety; Host-Pathogen Interactions; Immune System; Immune Tolerance; No-Observed-Adverse-Effect Level; Ovalbumin; Phenols; Pregnancy; Prenatal Exposure Delayed Effects; Respiratory Hypersensitivity; Risk Assessment

2016
Generation of IL10 and TGFB1 coexpressed mice displaying resistance to ovalbumin-induced asthma.
    Transgenic research, 2016, Volume: 25, Issue:6

    Asthma is a common chronic inflammatory disease in the airways with wide prevalence, and it is thought to be caused by the combinational factors in environment and genetics. A large body of studies has suggested that cell immunity played a vital role in regulating the airway hyperreactivity (AHR) and inflammation. Therefore, we here developed a mouse model of asthma by microinjecting the pronucleus with a vector spontaneously coding human IL10 and TGFB1 gene to explore the possible interaction between these two potent molecules during asthma progression. From the total 35 newborn mice, we successfully obtained 3 founders expressing exogenous genes. In the transgenic mice, we observed profoundly enhanced expression of IL10 and TGFB1. In the condition of ovalbumin challenge, transgenic mice displayed a 1.9-fold higher MCh50 score than wild-type counterparts, indicating reminiscent AHR. Meanwhile, a three-fold decrease of cell counts in bronchoalveolar lavage fluid (BALF) was recorded as well. These results suggested that IL10 and TGFB1 cooperatively protected the respiratory system in response to antigenic stimulus. To interrogate the respective behaviors of the two genes, we quantified the expression of downstream genes in IL10 signaling or TGFB1 signaling. We observed that the examined genes in IL10 signaling were significantly repressed, especially IL5, which showed 5.4-fold decreased expression. Most genes were not altered in TGFB1 signaling, and the production of endogenous TGFB1 was significantly inhibited. These evidences collectively proved that the activation of IL0 and TGFB1 protected the host from antigen-induced asthma, possibly through IL10 signaling. This study shed some light on the modulations of IL10 and TGFB1, and related networks to asthma progression.

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Disease Resistance; Gene Expression Regulation; Humans; Inflammation; Interleukin-10; Lung; Mice; Mice, Transgenic; Ovalbumin; Signal Transduction; Transforming Growth Factor beta1

2016
Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF(low) Alveolar Macrophages.
    Infection and immunity, 2015, Volume: 83, Issue:7

    Asthma is generally thought to confer an increased risk for invasive pneumococcal disease (IPD) in humans. However, recent reports suggest that mortality rates from IPD are unaffected in patients with asthma and that chronic obstructive pulmonary disease (COPD), a condition similar to asthma, protects against the development of complicated pneumonia. To clarify the effects of asthma on the subsequent susceptibility to pneumococcal infection, ovalbumin (OVA)-induced allergic lung inflammation (ALI) was induced in mice followed by intranasal infection with A66.1 serotype 3 Streptococcus pneumoniae. Surprisingly, mice with ALI were significantly more resistant to lethal infection than non-ALI mice. The heightened resistance observed following ALI correlated with enhanced early clearance of pneumococci from the lung, decreased bacterial invasion from the airway into the lung tissue, a blunted inflammatory cytokine and neutrophil response to infection, and enhanced expression of transforming growth factor β1 (TGF-β1). Neutrophil depletion prior to infection had no effect on enhanced early bacterial clearance or resistance to IPD in mice with ALI. Although eosinophils recruited into the lung during ALI appeared to be capable of phagocytizing bacteria, neutralization of interleukin-5 (IL-5) to inhibit eosinophil recruitment likewise had no effect on early clearance or survival following infection. However, enhanced resistance was associated with an increase in levels of clodronate-sensitive, phagocytic SiglecF(low) alveolar macrophages within the airways following ALI. These findings suggest that, while the risk of developing IPD may actually be decreased in patients with acute asthma, additional clinical data are needed to better understand the risk of IPD in patients with different asthma phenotypes.

    Topics: Allergens; Animals; Antigens, Differentiation, Myelomonocytic; Asthma; Disease Resistance; Female; Macrophages, Alveolar; Mice, Inbred BALB C; Ovalbumin; Pneumonia; Pneumonia, Pneumococcal; Sialic Acid Binding Immunoglobulin-like Lectins; Survival Analysis; Transforming Growth Factors

2015